Acalabrutinib With Rituximab and Lenalidomide in Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
Condition: Non-hodgkin Lymphoma,B Cell Intervention: Drug: Acalabrutinib Sponsor: Seoul National University Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials